Intellectual disability
Autism spectrum disorders
Global developmental delay
Epilepsy
Autism spectrum disorders
Global developmental delay
Epilepsy
.svg){kind=small}
Whole genome
embryo screening
Mitigate more risks by screening your IVF embryos before implantation
Talk to a Genetic CounselorWhole genome
embryo screening
Mitigate more risks by screening your IVF embryos before implantation.
Orchid is the only genetic testing provider that allows you to sequence 99% of your future baby's DNA.
Get StartedWHAT IS ORCHID?
Orchid overview
Orchid provides whole genome embryo screening that combines Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic/Single Gene Defects (PGT-M), and screens for hundreds of genes linked to severe monogenic diseases.
Orchid helps families maximize their chance for a successful pregnancy and healthy baby by screening embryos using whole genome sequencing.
Orchid helps families maximize their chance for a successful pregnancy and healthy baby by screening embryos using whole genome sequencing.
What we screen for
Use whole genome data to identify monogenic and polygenic diseases. Alternatives miss detecting risks because they do not sequence the whole genome.
Monogenic screening
Neurodevelopmental disorders
Pediatric and adult-onset cancers
Breast cancer
Prostate cancer
Pancreatic cancer
Retinoblastomas
Ovarian cancer
Colorectal cancer
Wilms' tumor
Prostate cancer
Pancreatic cancer
Retinoblastomas
Ovarian cancer
Colorectal cancer
Wilms' tumor
Birth defects
Heart, skeletal, cranial defects
Neuromuscular disorders
Vision and hearing loss
Neuromuscular disorders
Vision and hearing loss
Chromosomal abnormalities
Whole chromosomes
Microduplications/deletions
Molar pregnancies
Microduplications/deletions
Molar pregnancies
Get whole genome embryo screening
Make an informed decision with more data
Genetic predisposition screening
Brain health
Alzheimer’s disease
Bipolar disorder
Schizophrenia
Bipolar disorder
Schizophrenia
Heart health
Artial Fibrillation
Coronary artery disease
Coronary artery disease
Cancers
Breast cancer
Prostate cancer
Prostate cancer
General health
Celiac disease
Inflammatory bowel disease
Type I diabetes
Type II diabetes
Inflammatory bowel disease
Type I diabetes
Type II diabetes
Find the embryo at lowest risk for a disease that runs in your family
Estimate how much chronic disease risk can be mitigated
What we screen for
Use whole genome data to identify monogenic and polygenic diseases. Alternatives miss detecting risks because they do not sequence the whole genome.
Monogenic screening
Neurodevelopmental disorders
Intellectual disability
Autism spectrum disorders
Global developmental delay
Epilepsy
Autism spectrum disorders
Global developmental delay
Epilepsy
Pediatric and adult-onset cancers
Breast cancer
Prostate cancer
Pancreatic cancer
Retinoblastomas
Ovarian cancer
Colorectal cancer
Wilms' tumor
Prostate cancer
Pancreatic cancer
Retinoblastomas
Ovarian cancer
Colorectal cancer
Wilms' tumor
Birth defects
Heart, skeletal, cranial defects
Neuromuscular disorders
Vision and hearing loss
Neuromuscular disorders
Vision and hearing loss
Chromosomal abnormalities
Whole chromosomes
Microduplications/deletions
Molar pregnancies
Microduplications/deletions
Molar pregnancies
Genetic predispositions
Alzheimer's disease
Bipolar disorder
Schizophrenia
Atrial fibrillation
Coronary artery disease
Breast cancer
Prostate cancer
Celiac disease
Inflammatory bowel disease
Type I & II diabetes
Bipolar disorder
Schizophrenia
Atrial fibrillation
Coronary artery disease
Breast cancer
Prostate cancer
Celiac disease
Inflammatory bowel disease
Type I & II diabetes
Get whole genome embryo screening
Make an informed decision with more data
Genetic predisposition screening
Brain health
Alzheimer’s disease
Bipolar disorder
Schizophrenia
Bipolar disorder
Schizophrenia
Heart health
Artial Fibrillation
Coronary artery disease
Coronary artery disease
Cancers
Breast cancer
Prostate cancer
Prostate cancer
General health
Celiac disease
Inflammatory bowel disease
Type I diabetes
Type II diabetes
Inflammatory bowel disease
Type I diabetes
Type II diabetes
Find the embryo at lowest risk for a disease that runs in your family
Estimate how much chronic disease risk can be mitigated
.webp)
%201.webp)
Get whole genome embryo screening
Make an informed decision with more data
How it works
Get the most extensive reports for your embryos
Sequencing
Your IVF doctor orders Orchid on your behalf. An embryologist sends Orchid’s lab ~5 cells from each embryo, the same amount of material required for standard testing.
Reporting
Our team of experts reviews the genetic data and reports on the information requested for each embryo in your cycle.
Expert review
Meet with a board certified genetic counselor to explain the findings from the report, discuss specific risks related to each embryo tested, and answer any questions.
Ready to get started? Speak with a board certified genetic counselor.
Get accessWhat our customers say
"Orchid provided a lot more information than traditional PGT testing. I was really excited by the depth of information Orchid can provide. I would recommend Orchid for anyone that wants to maximize the amount of information that they're able to get. The more information you have now, the more you can learn from it in the future."
“Just like you would invest in the best schooling possible and the best food possible [for your child] - with Orchid, I feel like I've done the most responsible thing I could have done with the tools and the technology that we have today.”
“We found [the screening] to be super reassuring. We found the charts, graphs, and website to be super easy to read and understand, and it was also really nice meeting with the genetic counselor to discuss the results.”
“Orchid gave us clarity around the things that we care about, especially our family history of conditions. [It] gave us confidence that we can be parents again - it was really profoundly impactful.”
“This is the way to reduce disease and suffering in kids, and is the best thing you can do for your child and yourself. The fact that we have screened for so much gives us peace of mind. Understanding our genetics is a huge advantage.”
“We screened our embryos because were at risk for a hereditary cancer. Orchid found something more - we were carriers for the same condition. Without screening, 25% of our children could have the disease. Now, our kids are more likely to be healthy.”
“When we learned that PGT-WGS was an option we were onboard. Orchid let us screen our embryos for a range of inherited diseases. It's exciting that this technology is empowering parents to make informed choices.”
